Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
Luo P, Wang Y, Zhao C, Guo J, Shi W, Ma H, Liu T, Yan D, Huo S, Wang M, Li C, Lin J, Li S, Lv J, Zhang C, Lin L.
Luo P, et al. Among authors: huo s.
Eur J Pharmacol. 2021 Feb 15;893:173822. doi: 10.1016/j.ejphar.2020.173822. Epub 2020 Dec 23.
Eur J Pharmacol. 2021.
PMID: 33347820